Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01721083 · ClinicalTrials.gov registry record · Phase 4
Comparison of Two Methods of Immunization for Intramuscular Injections
A Phase 4 study of Consequences of Immunization Method, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- Phase 4
- Development phase
- 511
- Enrollment target
- 1
- Study location
NCT01721083: Completed Phase 4 study of Consequences of Immunization Method, sponsored by Christiana Care Health Services.
NCT01721083 is a Phase 4 study of Consequences of Immunization Method that has completed, run by Christiana Care Health Services. The registered enrollment target is 511 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01721083, a Phase 4 study of Consequences of Immunization Method, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 511 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to compare two different styles of intramuscular injection (Bunch versus Z-Track)during flu vaccination with the following outcome measures as basis for comparison: perceive pain, redness, medication leakage, other complications within 72 hours in healthy adult volunteer subjects.
Primary Outcome
Subjects will be asked to rate perceived pain on scale of 0-10
Conditions Studied
Interventions
- PROCEDURE Procedure: Z-track
- PROCEDURE Procedure: Bunch
Study Locations (1)
Delaware
- Christiana Care Health System - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-07 |
| Phase | Phase 4 |
What the finished NCT01721083 record still lists
NCT01721083 is an interventional study that assigns participants to a tested intervention. The registered 511 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 1 condition, with Consequences of Immunization Method appearing as the primary indexed condition, and to 2 interventions - of which Procedure: Z-track is the first listed.
NCT01721083 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT01721083 about?
NCT01721083 is a clinical study titled "Comparison of Two Methods of Immunization for Intramuscular Injections". This study is designed to compare two different styles of intramuscular injection (Bunch versus Z-Track)during flu vaccination with the following outcome measures as basis for comparison: perceive pain, redness, medication leakage, other complications within 72 hours in healthy adult volunteer subje...
What is the current status of trial NCT01721083?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 511 participants. The study started on 2012-10. Estimated completion is 2014-07.
What conditions does trial NCT01721083 study?
This clinical trial studies the following conditions: Consequences of Immunization Method.
What interventions are being tested in trial NCT01721083?
The interventions under investigation include: Procedure: Z-track (PROCEDURE), Procedure: Bunch (PROCEDURE).
Who is sponsoring clinical trial NCT01721083?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01721083 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01721083's enrollment target sits among peer trials
511 162nd of 2000 higher than 1,839 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia